Leadership Archives - Monimoi Therapeutics

Jennifer Rocnik, PhD

Kieran Chapman September 11, 2025 No Comments

Jenn brings over twenty years of scientific leadership and experience in drug discovery. Most recently she was an Entrepreneur-in-Residence at Third Rock Ventures working on incubating ideas and leading efforts…

Micah Niphakis, PhD

Kieran Chapman September 11, 2025 No Comments

Micah has over 10 years’ experience applying chemoproteomics to covalent drug discovery. Prior to joining Monimoi, he led the Platform Technology group at Lundbeck La Jolla Research Center where he…

Laura D’Agostino, PhD

Kieran Chapman September 11, 2025 No Comments

Laura, a Synthetic Chemist by training, brings over 19 years of drug discovery experience in covalent, targeted protein degradation and antibody drug conjugate modalities. Most recently, VP of Chemistry at Dunad…

Chris Mahoney

Kieran Chapman September 11, 2025 No Comments

Chris has over 16 years of scientific experience focused on target identification, validation and drug discovery in multiple areas of biology including oncology, metabolic disorders and cardiovascular disease. Bench leader…

Dylan Dieters-Castor, PhD

Kieran Chapman September 11, 2025 No Comments

Dylan is a proteomics scientist with over 10 years of experience using mass spectrometry-based proteomics to explore biological systems and advance drug discovery. Before joining Monimoi Therapeutics, he worked as…

Erika Whyte

Kieran Chapman September 11, 2025 No Comments

Erika brings over 18 years of experience in biotech and life sciences operations. She recently served as Chief of Staff and Vice President of Operations at ROME Therapeutics, where she…

Matt Callahan, PhD

Kieran Chapman September 11, 2025 No Comments

Matt is an Associate at The Column Group. He joined the firm in 2024 after completing his PhD in Chemical Biology with Jason Gestwicki at UCSF. Matt first gained exposure…

Tim Rasmussen, PhD

Kieran Chapman September 11, 2025 No Comments

Tim has over 17 years of experience across a range of chemistry and chemical biology disciplines, with a consistent focus on advancing early-stage portfolios and enabling innovative chemical technologies. His…

Ahmed Mady, PhD

Kieran Chapman September 11, 2025 No Comments

Ahmed is a biochemist with nearly a decade of experience advancing drug discovery programs from hit identification through IND submission. He has held senior scientific roles in biotech, including Associate…

Jeffrey Ecsedy, PhD

Kieran Chapman September 11, 2025 No Comments

Jeff brings over 22 years of experience in cancer research and drug development. Most recently, he served as Chief Scientific and Development Officer at Ikena Oncology, where he led research…

Team Category: Leadership